Skip to content

Public FDA record

Z-0150-2022: HemosIL Liquid Anti-Xa- automated chromogenic assay for in vitro diagnostic use by laboratory professiona

Recall record Z-0150-2022 for Instrumentation Laboratory. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0150-2022
Company in FDA record
Instrumentation Laboratory
FDA record creation date
Oct 19, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Labeled On-board instrument stability issue for current and future lots, reduced On-board Instrument Stability from 7 days to 5 days

Source facts

Action
Werfen issued Urgent Medical Device Correction letter via email via email or registered mail on 9/7/21. Letter states reason for recall, health risk and action to take: NOTE: Please refer to the separate "URGENT Medical Device Removal" notice (dated August 25, 2021) for Hemosll Liquid Anti-Xa, Part No. 0020302600, which removes claims for this assay from the ACL Elite and ACL Elite Pro instruments. " Mandatory Customer Actions At this time, the on-board instrument stability claim has been reduced from 7 days to 5 days for all in-date and future product lots of Hemosll Liquid Anti-Xa (Part Nos. 0020302600 and 0020302602) on the ACL TOP Family and ACL TOP Family 50 Series. Please take the following immediate actions: " Use the following reduced on-board instrument stability claim for Hemosll Liquid Anti-Xa (Part Nos. 0020302600 and 0020302602) on the ACL TOP Family and ACL TOP Family 50 Series. ACL TOP Family and ACL TOP Family 50 Series Current On-board Instrument Stability Reduced On-board Instrument Stability 7 Days 5 Days " Run quality controls before patient testing or every 8 hours and with each new vial in accordance with good laboratory practice. " Post this notification on each of your ACL TOP Family and ACL TOP Family 50 Series instruments. " Share this information with your staff, notifying them of the reduced on-board stability requirement of 5 Days for the ACL TOP Family and ACL TOP Family 50 Series. " Retain a copy of this letter in your files as a record of the notification. " Complete and return the enclosed Mandatory Response Tracking Form to acknowledge the above actions. " Return the completed and signed form immediately to: " Fax No.: 781-861-4207 " E-mail: ra-usa.na@werfen.com NOTE: Please return the tracking form even if you do not have any inventory of Hemosll Liquid Anti-Xa (Part Nos. 0020302600 and 0020302602). " Contact Information for Questions " For technical questions, please contact the Technical Support Center at 1-8
Initiated
2021-08-25
Root cause
Device Design
Distribution
US Nationwide Foreign: Canada Armenia Austria Australia Belgium Brunei Brazil Belarus Switzerland China Colombia Czech Republic Germany Denmark Spain Finland France United Kingdom Gibraltar Greece Hong Kong Hungary Indonesia Ireland Israel India Iran Italy¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿ Japan South Korea Kuwait Kazakhstan Lebanon Sri Lanka Lithuania Luxembourg Macau Mexico Malaysia Netherlands Poland Portugal Qatar Reunion Romania Serbia Russia Saudi Arabia Sweden Thailand Tunisia Turkey Taiwan Vietnam Zambia
Recall number
Z-0150-2022
Recall status
Open, Classified
CDRH record ID
189121
FDA record created
2021-10-19
Recall event number
88627

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗